Ricerca

 

  • "Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease" Experts of the European Horizon2020 Marie Skłodowska Curie project “Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease” met at the Department of Physiology and Pharmacology “Erspamer” of Sapienza University of Rome (March 19th-21st, 2018) to discuss a new plan for the monitoring of blood biomarkers, cognitive functions, and lifestyle in patients with Alzheimer’s disease at point of care by innovative graphene-based devices and information and communication technology services